CD5 Stock Chart & Stats
€0.60
€0.03(2.89%)
At close: 4:00 PM EDT
€0.60
€0.03(2.89%)
Day’s Range― - ―
52-Week Range€0.52 - €3.56
Previous CloseN/A
Volume0.00
Average Volume (3M)197.00
Market Cap
€8.79M
Enterprise Value€26.94
Total Cash (Recent Filing)€886.47K
Total Debt (Recent Filing)€10.34M
Price to Earnings (P/E)―
Beta0.44
Next Earnings
Nov 05, 2026EPS Estimate
-0.16Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.30
Shares Outstanding16,483,080
10 Day Avg. Volume593
30 Day Avg. Volume197
Financial Highlights & Ratios
PEG Ratio0.48
Price to Book (P/B)3.62
Price to Sales (P/S)0.42
P/FCF Ratio-10.71
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
€2.80Price Target Upside366.81% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering3
EPS Forecast (FY)-0.42
Revenue Forecast (FY)€27.12M
Bulls Say, Bears Say
Bulls Say
Audience Modeling GrowthGrowth in audience modeling indicates that IntentKey is gaining commercial traction while the company transitions away from legacy search. Increasing revenue from this product, supported by new wins and deeper existing-customer spend, can create a more durable platform-led growth engine.
Operating Cost RationalizationThe substantial reduction in operating expenses and headcount lowers the cost base and may improve operating leverage if revenue stabilizes. Rightsizing also demonstrates management action to align resources with the company’s strategic shift toward audience modeling and more focused growth opportunities.
Improved Financing FlexibilityFresh financing and debt repayment provide additional working capital and reduce immediate balance-sheet pressure during the business transition. This funding can support ongoing operations, product development, and customer expansion while management works toward improved revenue and cash-flow performance.
Bears Say
Revenue And Margin DeteriorationThe sharp decline in revenue and gross margin signals significant pressure on the current earnings base. Weaker scale and a less favorable mix reduce operating leverage, making a return to profitability more difficult unless audience modeling growth can offset the continuing deterioration in legacy search.
Negative Cash GenerationPersistent negative operating and free cash flow means the business is not currently funding itself through operations. Continued cash consumption can constrain investment and increase dependence on external financing, especially if revenue recovery or margin improvement takes longer than management expects.
Legacy Search Structural PressureStructural changes in digital advertising are weakening legacy search, including privacy-related signal loss, platform concentration, and AI-driven search disruption. Because this business remains part of the company’s revenue base, prolonged decline can offset product gains and keep the overall transition financially difficult.
Inuvo News
CD5 FAQ
What was Inuvo Inc’s price range in the past 12 months?
Inuvo Inc lowest stock price was €0.52 and its highest was €3.56 in the past 12 months.
What is Inuvo Inc’s market cap?
Inuvo Inc’s market cap is €8.79M.
When is Inuvo Inc’s upcoming earnings report date?
Inuvo Inc’s upcoming earnings report date is Nov 05, 2026 which is in 53 days.
How were Inuvo Inc’s earnings last quarter?
Inuvo Inc released its earnings results on Aug 11, 2026. The company reported -€0.231 earnings per share for the quarter, missing the consensus estimate of -€0.21 by -€0.021.
Is Inuvo Inc overvalued?
According to Wall Street analysts Inuvo Inc’s price is currently Undervalued.
Does Inuvo Inc pay dividends?
Inuvo Inc does not currently pay dividends.
What is Inuvo Inc’s EPS estimate?
Inuvo Inc’s EPS estimate is -0.16.
How many shares outstanding does Inuvo Inc have?
Inuvo Inc has 16,483,080 shares outstanding.
What happened to Inuvo Inc’s price movement after its last earnings report?
Inuvo Inc reported an EPS of -€0.231 in its last earnings report, missing expectations of -€0.21. Following the earnings report the stock price went down -4.678%.
Which hedge fund is a major shareholder of Inuvo Inc?
Currently, no hedge funds are holding shares in DE:CD5
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Inuvo Inc
Inuvo, Inc., an advertising technology and services company, develops and commercializes large language generative artificial intelligence that discovers and targets digital audiences in the United States. The company offers IntentKey, an artificial intelligence, data analytics, and automation tool that can optimize the purchase and placement of advertising in real time without consumer data, which can serve multiple creative formats including agencies and brands; CTV, video, audio, native, display channels; and platform. The company sells its information technology solutions to agencies, brands, and large consolidators of advertising demand. It markets its products through websites, social media platforms, blogs, public relations, trade shows, and conferences. The company is headquartered in Little Rock, Arkansas.
CD5 Earnings Call
Q2 2026
0:00 / 0:00
Earnings Call Sentiment|Neutral
The call describes a company in active strategic transition: severe near‑term revenue and margin pressure driven by an ongoing collapse in legacy search, but meaningful progress on reshaping the business—audience modeling growth, a strengthened sales organization, product innovation, cost rationalization, and fresh capital to extend the runway. The positives demonstrate a credible path forward centered on IntentKey, but short‑term financial headwinds, tight reported liquidity at quarter‑end, and dependency on converting pipeline and contingent funds create material near‑term risks.View all DE:CD5 earnings summariesCD5 Stock 12 Month Forecast
Average Price Target
€2.80
▲(366.81% Upside)